Skip to main content
Clinical Trials/NL-OMON23276
NL-OMON23276
Recruiting
Not Applicable

An independent prospective randomised controlled trial comparing the efficacy and cost effectiveness of infliximab and etanercept in 'high need' patients with moderate to severe chronic plaque type psoriasis.

Academic Medical Center (AMC), Department of dermatology0 sites120 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Psoriasis, Etanercept, Infliximab, Cost-effectiveness (kosteneffectiviteit)
Sponsor
Academic Medical Center (AMC), Department of dermatology
Enrollment
120
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Academic Medical Center (AMC), Department of dermatology

Eligibility Criteria

Inclusion Criteria

  • 1\. Adults patients (18\-75 years of age)
  • 2\. Psoriasis Area and Severity Index (PASI \> 10\) and/or Body Surface Area (BSA) \> 10\.

Exclusion Criteria

  • 1\. Pregnancy and lactation.
  • 2\. Active (or chronic) infections including Hepatitis B and C viral infections, HIV and tuberculosis.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 4
An independent prospective randomised controlled trial comparing the efficacy and cost effectiveness of infliximab and etanercept in 'high need' patients with moderate to severe chronic plaque type psoriasischronic skin disease with increased keratinizationpsoriasis10011063
NL-OMON35488Academisch Medisch Centrum120
Active, not recruiting
Not Applicable
An independent prospective randomised controlled trial comparing the efficacy and cost effectiveness of infliximab and etanercept in 'high need' patients with moderate to severe chronic plaque type psoriasis - PIECEPatients with moderate to severe chronic plaque type psoriasis (Psoriasis Area and Severity Index (PASI > 10) and/or Body Surface Area (BSA) > 10) who failed or have contraindications and/or are intolerant to ultraviolet therapy, methotrexate or cyclosporin.MedDRA version: 9.1Level: LLTClassification code 10050577Term: Psoriatic plaque
EUCTR2008-007492-24-NLAcademic Medical Center120
Recruiting
Not Applicable
A prospective randomised controlled trial in the treatment of anal fissures; Botulin-A Toxin versus Topical Diltiazem: BOTTOM-trial.Anal fissure (NLD: anale fissuur).
NL-OMON29443B.A. Twigt, E.A te Velde, L. Stoker, E. Kuck, A. Pronk164
Not yet recruiting
Not Applicable
Results of cast treatment and percutaneous achilles tendon lengthening for children with an achilles tendon contracture.idiopatic toe walkers: children who walked on their toes after de age of two and children who has a symptomatic equinus contracture (ankle dorsiflexion between -10 and 3 degree).
NL-OMON21028wetenschapsbureau Linneus Instituut Spaarne ziekenhuis78
Recruiting
Not Applicable
A prospective, controlled, randomized, assessor-blind, comparative study of a new oral bowel cleanser (Sodium Picosulfate/Magnesium Citrate) versus existing oral bowel cleanser (Magnesium Citrate) in pediatric colonoscopy preparation.Inflammatory bowel disease, Functional gastrointestinal disorders, Eosinophilic gastroenteritis, Colorectal polyps, others
JPRN-UMIN000046015Saitama children's Medical Center Division of Gastroenterology and Hepatology126